Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Lymphoma, Follicular 1067Lymphoma, Large B-Cell, Diffuse 1060Hodgkin Disease 906Leukemia 877Lymphoma, Mantle-Cell 738Leukemia, Myeloid, Acute 662Burkitt Lymphoma 604Multiple Myeloma 556Lymphoma, B-Cell, Marginal Zone 546Myelodysplastic Syndromes 507Recurrence 451Lymphoma, B-Cell 415Lymphoma, Large-Cell, Immunoblastic 328Waldenstrom Macroglobulinemia 323Lymphoma, T-Cell, Cutaneous 322Mycosis Fungoides 277Neoplasms 257Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Myeloproliferative Disorders 249Neoplasms, Plasma Cell 242Sezary Syndrome 231Leukemia, Myelogenous, Chronic, BCR-ABL Positive 221Lymphoma, Large-Cell, Anaplastic 215Leukemia, Myeloid, Accelerated Phase 211Lymphoma, T-Cell, Peripheral 205Blast Crisis 203

Interventions

Daptomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Soft Tissue Infections × Lymphoid × Clear all
NCT00261807 2022-01-27

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

University of Maryland, Baltimore

Phase NA Completed
25 enrolled 7 charts
Lymphoid

Infections, Lymphoma, Follicular, Soft Tissue Infections, Fournier Gangrene, Fasciitis, Necrotizing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡